These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7047714)

  • 1. Enhanced peripheral glucose utilization and suppressed hepatic glycogen synthesis in KK mice treated with islet-activating protein (IAP).
    Okamoto T; Yajima M
    J Pharmacobiodyn; 1982 Mar; 5(3):148-54. PubMed ID: 7047714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of diabetic symptoms of hereditary diabetic (KK) mice by a single injection with islet-activating protein (IAP).
    Okamoto T; Itoh A; Yajima M; Ui M
    J Pharmacobiodyn; 1980 Sep; 3(9):470-7. PubMed ID: 6257880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of islet activating protein on glucose tolerance, insulin secretion and insulin responsiveness in the NZO mouse.
    Re CA; Veroni MC; Larkins RG
    Diabetologia; 1984 Apr; 26(4):304-9. PubMed ID: 6376239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of islet-activating protein on insulin- and isoprenaline-stimulated glucose transport in isolated rat adipocytes.
    Joost HG; Göke R
    FEBS Lett; 1984 Feb; 167(1):5-9. PubMed ID: 6365589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species differences in actions of islet-activating protein, pertussis toxin.
    Yajima M; Okamoto T; Kurokawa S; Itoh A; Terashima A; Ui M
    Jpn J Pharmacol; 1983 Jun; 33(3):583-91. PubMed ID: 6353019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of islet activating protein on oral glucose tolerance in the genetically obese fa/fa rat.
    Proietto J; Rohner-Jeanrenaud F; Ionescu E; Jeanrenaud B
    Metabolism; 1989 Apr; 38(4):338-42. PubMed ID: 2657321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of islet-activating protein (IAP) upon insulin secretion from human pancreatic islets.
    Araki Y; Yoshida T; Nakamura N; Koyama K; Nakamura Y; Nakano K; Kondo M
    Endocrinol Jpn; 1981 Apr; 28(2):139-43. PubMed ID: 7030721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of islet-activating protein (IAP) on blood glucose and plasma insulin in healthy volunteers (phase 1 studies).
    Toyota T; Kai Y; Kakizaki M; Sakai A; Goto Y; Yajima M; Ui M
    Tohoku J Exp Med; 1980 Feb; 130(2):105-16. PubMed ID: 6247781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo glycogen and lipid synthesis by various tissues from normal and metformin-treated KK mice.
    Jyothirmayi GN; Jayasundaramma B; Reddi AS
    Res Commun Chem Pathol Pharmacol; 1992 Oct; 78(1):113-6. PubMed ID: 1462045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet-activating protein (IAP)-induced adrenergic modulation of pancreatic A and B cell in dogs.
    Nakamura N; Yoshida T; Nakamura Y; Araki Y; Nakano K; Kanatsuna T; Kondo M
    Horm Metab Res; 1984 Mar; 16(3):128-31. PubMed ID: 6370819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet-activating protein (IAP) reduces bethanechol-stimulated release of pancreatic polypeptide in the dog.
    Hanafusa T; Toyoshima H; Nonaka K; Tarui S
    Endocrinol Jpn; 1982 Jun; 29(3):357-61. PubMed ID: 6756897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of islet-activating protein (IAP) of pertussis toxin on the spontaneous diabetic syndrome in the rat.
    Bergada I; Colle E; Seemayer TA
    Diabetes Res; 1989 Jun; 11(2):85-91. PubMed ID: 2695283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of islet-activating protein (IAP), purified from the culture medium of Bordetella pertussis, on the secretion of immunoreactive insulin and glucagon in normal, alloxan-treated, and depancreatized dogs.
    Yoshida T; Nakamura Y; Nakano K; Kondo M
    Diabetes; 1981 May; 30(5):430-4. PubMed ID: 6262169
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro effects of islet-activating protein on cultured rat pancreatic islets. Enhancement of insulin secretion, adenosine 3':5'-monophosphate accumulation and 45Ca flux.
    Katada T; Ui M
    J Biochem; 1981 Apr; 89(4):979-90. PubMed ID: 6166608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifedipine, a calcium-channel blocker, attenuated glucose intolerance and white adipose tissue dysfunction in type 2 diabetic KK-A(y) mice.
    Iwai M; Kanno H; Inaba S; Senba I; Sone H; Nakaoka H; Horiuchi M
    Am J Hypertens; 2011 Feb; 24(2):169-74. PubMed ID: 20847723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct renin inhibition improved insulin resistance and adipose tissue dysfunction in type 2 diabetic KK-A(y) mice.
    Iwai M; Kanno H; Tomono Y; Inaba S; Senba I; Furuno M; Mogi M; Horiuchi M
    J Hypertens; 2010 Jul; 28(7):1471-81. PubMed ID: 20543712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental study on carbohydrate metabolism and pancreatic endocrine function after pancreatectomy--influence of islet activating protein (IAP)].
    Adachi K; Ohyanagi H; Nakaya M; Saitoh Y
    Nihon Geka Gakkai Zasshi; 1986 Jan; 87(1):67-78. PubMed ID: 3960025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic metformin treatment of hepatic and muscle glycogen metabolism in KK mice.
    Reddi AS; Jyothirmayi GN
    Biochem Med Metab Biol; 1992 Apr; 47(2):124-32. PubMed ID: 1515171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose load diverts hepatic gluconeogenic product from glucose to glycogen in vivo.
    Shikama H; Ui M
    Am J Physiol; 1978 Oct; 235(4):E354-60. PubMed ID: 100016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-hyperglycemic Effect of Long-Term Bis(hinokitiolato)zinc Complex ([Zn(hkt)
    Naito Y; Yoshikawa Y; Shintani M; Kamoshida S; Kajiwara N; Yasui H
    Biol Pharm Bull; 2017; 40(3):318-326. PubMed ID: 28250273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.